Institut Català de la Salut
[Brownlee WJ] Queen Square Multiple Sclerosis Center, Department of Neuroinflammation, UCL Institute of Neurology, London, UK. NIHR University College London Hospitals Biomedical Research Center, London, UK. [Vidal-Jordana A, Bollo L, Sastre-Garriga J] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Shatila M] Queen Square Multiple Sclerosis Center, Department of Neuroinflammation, UCL Institute of Neurology, London, UK. [Strijbis E, Schoof L, Killestein J] Multiple Sclerosis Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam University Medical College VUMC, Amsterdam, the Netherlands. [Rovira A] Secció of Neuroradiologia, Servei de Radiodiagnòstic, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Tintore M, Montalban X] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. Universitat de Vic-Universitat Central de Catalunya, Vic, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-03-10T12:33:35Z
2025-03-10T12:33:35Z
2024
2025-03
Diagnostic; Multiple sclerosis
Diagnóstico; Esclerosis múltiple
Diagnòstic; Esclerosi múltiple
Objective The 2017 McDonald criteria continued the separation of diagnostic criteria for relapsing–remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS) for historical, rather than biological, reasons. We aimed to explore the feasibility of a single, unified set of diagnostic criteria when applied to patients with suspected PPMS. Methods We retrospectively identified patients evaluated for suspected PPMS at 5 European centers. The 2017 McDonald PPMS criteria was the gold standard against which the 2017 McDonald RRMS dissemination in space (DIS) and dissemination in time criteria were evaluated. We also investigated modified RRMS DIS criteria, including: (i) optic nerve lesions; (ii) ≥2 spinal cord lesions; and (iii) higher fulfilment of DIS criteria alone (lesions in ≥3 regions) without dissemination in time/positive cerebrospinal fluid, for a diagnosis of PPMS. Results A total of 282 patients were diagnosed with PPMS using the 2017 McDonald criteria, and 40 with alternate disorders. The 2017 McDonald RRMS DIS criteria and the modified DIS criteria including the optic nerve or ≥2 spinal cord lesions performed well in PPMS diagnosis when combined with dissemination in time/positive cerebrospinal fluid (sensitivity 92.9–95.4%, specificity 95%, accuracy 93.2–95.3%). A diagnosis of PPMS based on high fulfillment of modified RRMS DIS criteria had high specificity, but low sensitivity. A diagnostic algorithm applicable to patients evaluated for suspected MS is proposed. Interpretation The 2017 McDonald RRMS criteria and modifications to DIS criteria, currently under consideration, performed well in PPMS diagnosis. Forthcoming revisions to the McDonald criteria should consider a single, unified set of diagnostic criteria for MS. ANN NEUROL 2025;97:571–582
Artículo
Versión publicada
Inglés
Esclerosi múltiple - Diagnòstic; Medul·la espinal - Ferides i lesions; Nervi òptic - Malalties; DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Relapsing-Remitting; DISEASES::Nervous System Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis::Multiple Sclerosis, Chronic Progressive; Other subheadings::Other subheadings::/diagnosis; ANATOMY::Nervous System::Peripheral Nervous System::Peripheral Nerves::Cranial Nerves::Optic Nerve; DISEASES::Nervous System Diseases::Central Nervous System Diseases::Spinal Cord Diseases::Spinal Cord Injuries; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple recurrente-remitente; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple::esclerosis múltiple crónica progresiva; Otros calificadores::Otros calificadores::/diagnóstico; ANATOMÍA::sistema nervioso::sistema nervioso periférico::nervios periféricos::nervios craneales::nervio óptico; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades del sistema nervioso central::enfermedades de la médula espinal::traumatismos de la médula espinal
Wiley
Annals of Neurology;97(3)
https://doi.org/10.1002/ana.27145
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - CEMCAT [136]
Articles científics - HVH [3396]